Genomic Landscape and Clinical Features of Carcinomas with ERBB2 S310 Extracellular Domain Mutations

被引：0
|
作者：
Desmeules, Patrice [1 ]
Zehir, Ahmet [1 ]
Hyman, David M. [1 ]
Arcila, Maria E. [1 ]
Ladanyi, Marc [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1831
引用
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [41] Targeting oncoprotein stability overcomes lapatinib-resistance due to ERBB2 kinase domain mutations
    Kancha, R. K.
    Blaeschke, F.
    Bartosch, N.
    Peschel, C.
    Duyster, J.
    ONKOLOGIE, 2012, 35 : 109 - 110
  • [42] Targeting oncoprotein stability overcomes lapatinib-resistance due to ERBB2 kinase domain mutations
    Kancha, Rama Krishna
    Blaeschke, Franziska
    Bartosch, Natalie
    Peschel, Christian
    Duyster, Justus
    CANCER RESEARCH, 2012, 72
  • [43] Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in ERBB2
    Liu, Yuzhi
    Bischof, Evelyne
    Chen, Zhiqin
    Zhou, Jiahuan
    Zhang, Bei
    Zhang, Ding
    Gao, Yong
    Quan, Ming
    ONCOLOGY RESEARCH, 2024, 32 (09) : 1429 - 1438
  • [44] Successful treatment of a patient with Li-Fraumeni syndrome and metastatic lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with the pan-HER inhibitor afatinib
    Jia, Yuxia
    Ali, Siraj M.
    Saad, Shumaila
    Chan, Courtney A.
    Miller, Vincent A.
    Halmos, Balazs
    CANCER BIOLOGY & THERAPY, 2014, 15 (08) : 970 - 974
  • [45] Genomic landscape analysis of ERBB3-mutated human cancers reveals common co-occurrence with activating ERBB2 alterations
    Odintsov, I.
    Somwar, R.
    Ladanyi, M.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S149 - S149
  • [46] Genomic Landscape Analysis of ERBB3-mutated Human Cancers Reveals Common Co-Occurrence with Activating ERBB2 Alterations
    Odintsov, Igor
    Somwar, Romel
    Ladanyi, Marc
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1255 - 1255
  • [47] A high frequency of activating extracellular domain ERBB2 (HER2) mutation in micropapillary urothelial carcinoma.
    Wang, Kai
    Ross, Jeff S.
    Gay, Laurie M.
    Al-Rohil, Rami N.
    Nazeer, Tipu
    Sheehan, Christine E.
    Jennings, Timothy A.
    Otto, Geoff A.
    Donahue, Amy
    He, Jie
    Palmer, Gary
    Ali, Siraj
    Nahas, Michelle
    Young, Geneva
    LaBrecque, Elaine
    Frampton, Garrett
    Erlich, Rachel
    Curran, John A.
    Brennan, Tina
    Downing, Sean R.
    Yelensky, Roman
    Lipson, Doron
    Hawryluk, Matthew J.
    Miller, Vincent A.
    Stephens, Philip J.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [48] Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity
    Liang Chang
    Changhai Zhou
    Man Xu
    Jing Liu
    Journal of Computer-Aided Molecular Design, 2010, 24 : 37 - 47
  • [49] Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity
    Chang, Liang
    Zhou, Changhai
    Xu, Man
    Liu, Jing
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2010, 24 (01) : 37 - 47
  • [50] A Rare Case of S310F Somatic ERBB2 Mutation in a HER2-Nonamplified Breast Cancer
    Jasra, Sakshi
    Opyrchal, Mateusz
    Norton, Larry
    Mehta, Rutika
    CLINICAL BREAST CANCER, 2017, 17 (01) : E37 - E41
12345